Preclinical Development of a Gene Therapy for Dravet Syndrome
A recent publication from Tanenhaus et al details the preclinical work by Encoded Therapeutics that has led to the development of a potential gene regulation therapy for Dravet syndrome. The study, published in the journal Human Gene Therapy in June, shows proof-of-concept that their approach, ETX101, can be delivered to the correct cells in the […]
Preclinical Development of a Gene Therapy for Dravet Syndrome Read More »